Veracyte Inc (VCYT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Veracyte Inc-Aktie (VCYT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.65% 140.64	131.87	130.16	114.47	115.86
Cost Of Revenue	4.75% 38.66	40.59	40.40	34.97	36.85
Gross Profit	11.71% 101.97	91.28	89.77	79.51	79.01
Operating Expenses	5.21% 64.78	68.34	95.04	76.60	66.99
Benefits Costs and Expenses	11.49% 100.00	112.98	128.91	107.05	99.01
Costs And Expenses	5.21% 64.78	68.34	95.04	76.60	66.99
Operating Income/Loss	62.10% 37.20	22.95	-5.268	2.904	12.02
Income/Loss From Continuing Operations Before Tax	115.12% 40.63	18.89	1.25	7.428	16.85
Income Tax Expense/Benefit	107.66% -0.515	-0.248	2.23	0.381	1.693
Income/Loss From Continuing Operations After Tax	115.02% 41.15	19.14	-0.98	7.047	15.15
Net Income/Loss	115.02% 41.15	19.14	-0.98	7.047	15.15
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.75% 0.2001	78.73	78.39	78.03	77.01
Diluted Average Shares	99.21% 0.6268	79.69	78.39	80.06	78.46
Basic Earnings Per Share	116.67% 0.52	0.24	-0.01	0.09	0.20
Diluted Earnings Per Share	108.33% 0.50	0.24	-0.01	0.09	0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

DGX

$192.88

1.19%

ILMN

$145.22

0.56%

MTD

$1,101.33

0.16%

IQV

$162.00

3.51%

NTRA

$200.91

1.12%

$115.08

0.10%